Investigations Into the Function of Structural Isoforms of the Platelet Derived Growth Factor A-Chain

Total Page:16

File Type:pdf, Size:1020Kb

Investigations Into the Function of Structural Isoforms of the Platelet Derived Growth Factor A-Chain Investigations into the function of structural isoforms of the Platelet Derived Growth Factor A-chain. Richard Alan Pollock Department of Biology Medawar Building University College London Gower Street London WC1E 6BT. A Thesis submitted to the University of London for the degree of Ph.D ProQuest Number: 10609352 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest 10609352 Published by ProQuest LLC(2017). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 To My Sister, Louise. Abstract. Platelet derived growth factor (PDGF) is a covalent dimer of A and B chains with the structure AB, AA or BB depending on its source. The A and B chains are related but distinct polypeptides encoded by separate genes. PDGF-A can be differentially spliced, allowing production of two mature proteins one of which (PDGF-Al) is longer than the other (PDGF-As) by 15 amino acids at its carboxyl terminus. PDGF-A homodimers are thoughtto be important in early development and, later, for regulating glial cell development in the central nervous system (CNS). In order to gain a clearer understanding of the role of PDGF in vivo it is important to define the functional significance of the different isoforms and their cellular sources and targets. This thesis describes my attempts to elucidate the functional differences between PDGF-As and PDGF-Al and to determine whether they are differentially expressed in CNS derived tissues. To investigate the functional differences between PDGF-As and PDGF-A l I introduced plasmid vectors directing the expression of the two isoforms into cultured Cos cells and subjected the expressed molecules to biochemical and immunocytochemical analysis. These studies provide evidence that PDGF-As is secreted as a freely diffusible molecule while PDGF-A l is sequestered near the cells that produce it by binding to heparin-like molecules on the cell surface and in the extracellular matrix (ECM). The implications of these findings are discussed with reference to other factors that exist in different isoforms that are either freely diffusible or immobilised at the cell surface and within the ECM. I attempted to analyse the expression pattern in the CNS of the two isoforms by a combination of techniques, including SI nuclease protection, PCR amplification on reverse transcribed RNA, cDNA cloning and sequencing. These studies suggest that PDGF-As predominates in the tissues and cell types I have examined in agreement with other studies of a similar nature. Acknowledgements I would like to thank my supervisor Dr. W. D. Richardson for help and guidance throughout my time in his lab and during the preparation of this thesis. I would also like to thank others in the lab and members of the biology department including Mike Mosely for making some of the expression vectors in the appendix, Dr. Nigel Pringle and Dr. Leon Nawrocki for their useful advice and for proof reading Chapter 2, Dr. Tessa Crompton for the invaluable and over-extended loan of her Mac, Dr. Bob Harris for his advice and virus club companionship, Dr. Barbara Barres for keeping me enthusiastic late into the night, Dr. Colin Hodgkinson for his music and dancing (sorry about the tupperware) and Georgina Stevens for her encouragement in the later stages. I would also like to thank my flatmate Adam Leibowitz for his consistent and oft amusing floccinaucinihilipilification during our years together in CamberHell and those who encouraged me when I needed it and put up with me the rest of the time including David, Robert, Karen, Zde, Anthony, Billy, Paul, Rab, and Jazz. Finally I would like to thank my grand parents, my sister and my mother and father whose support (financial and moral) and tireless encouragement throughout this, as with everything, has been beyond value. Thank you. List of Contents. Title p a g e ............................................................................................................................ 1 Dedication ............................................................................................................................2 Abstract ................................................................................................................................ 3 Acknowledgements ...........................................................................................................4 List of Contents ....................................................................................................................5 List of Figures ..................................................................................................................... 10 List of T ables........................................................................................................................16 Abbreviations ..................................................................................................................... 17 Chapter 1. Introduction ....................................................................................................20 1.1 Growth factors act by binding to cell surface receptors ...........................20 1.2 Growth factors can be grouped into families based on sequence similarity .................................................................................................21 A) Insulin and the insulin like growth factors (IGFs) ......................... 21 B) The epidermal growth factor (EGF) family ...................................... 22 C) The transforming growth factor beta (TGF-p) family ....................23 D) The fibroblast growth factor (FGF) family ...................................... 25 The fibroblast growth factor receptor (FGFr) family............................................................................................... 27 Fibroblast growth factors and heparin binding ......................29 E) The hemopoietic and neuropoietic growth factors ........................32 F) The platelet derived growth factor (PDGF) family ......................... 37 The role of PDGF in the vascular system ..................................37 Abnormal PDGF activity and proliferative disease .................38 PDGF and Neoplasia ...................................................................... 39 PDGF in development ................................................................... 40 Alternative splicing of PDGF A-chain mRNA ............................42 1.3 Aims of thesis ....................................................................................................44 Chapter 2. Materials and Methods ................................................................................49 2.1 Bacteriology ......................................................................................................49 A) Bacterial strains .....................................................................................49 B) Growth media and agar plates ............................................................49 C) Preparation of competent bacteria ....................................................50 i) Calcium chloride method .......................................................50 ii) Hexamine cobalt chloride method ........................................ 50 D) Transformation of bacteria with DNA ...............................................50 E) Long-term storage of recombinant bacteria .....................................51 2.2 Molecular biology ............................................................................................ 51 A) Phenol/chloroform extractions ...........................................................51 B) Ethanol precipitation of nucleic acids ...............................................51 C) Restriction digest of DNA ..................................................................... 52 D) End labelling of DNA fragments .........................................................52 E) Dephosphorylation of DNA termini ................................................... 52 F) Ligation of DNA ....................................................................................... 53 G) Screening plasmid DNA from transformed bacterial colonies .......................................................................................................... 53 i) Plasmid mini preparation ......................................................... 53 ii) Transformed bacterial colony lifts and hybridisation ....................................................................................53 H) "Maxi" plasmid preparation ................................................................ 54 I) Preparation of genomic DNA ................................................................ 55 J) Preparation of RNA ................................................................................. 55 K) Poly (A)+ selection ................................................................................. 56 L) Electrophoretic analysis of nucleic acids .......................................... 56 i) Agarose gels ..................................................................................56
Recommended publications
  • EMBC Annual Report 2007
    EMBO | EMBC annual report 2007 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION | EUROPEAN MOLECULAR BIOLOGY CONFERENCE EMBO | EMBC table of contents introduction preface by Hermann Bujard, EMBO 4 preface by Tim Hunt and Christiane Nüsslein-Volhard, EMBO Council 6 preface by Marja Makarow and Isabella Beretta, EMBC 7 past & present timeline 10 brief history 11 EMBO | EMBC | EMBL aims 12 EMBO actions 2007 15 EMBC actions 2007 17 EMBO & EMBC programmes and activities fellowship programme 20 courses & workshops programme 21 young investigator programme 22 installation grants 23 science & society programme 24 electronic information programme 25 EMBO activities The EMBO Journal 28 EMBO reports 29 Molecular Systems Biology 30 journal subject categories 31 national science reviews 32 women in science 33 gold medal 34 award for communication in the life sciences 35 plenary lectures 36 communications 37 European Life Sciences Forum (ELSF) 38 ➔ 2 table of contents appendix EMBC delegates and advisers 42 EMBC scale of contributions 49 EMBO council members 2007 50 EMBO committee members & auditors 2007 51 EMBO council members 2008 52 EMBO committee members & auditors 2008 53 EMBO members elected in 2007 54 advisory editorial boards & senior editors 2007 64 long-term fellowship awards 2007 66 long-term fellowships: statistics 82 long-term fellowships 2007: geographical distribution 84 short-term fellowship awards 2007 86 short-term fellowships: statistics 104 short-term fellowships 2007: geographical distribution 106 young investigators 2007 108 installation
    [Show full text]
  • Identification of the C-Terminal Activator Domain in Yeast Heat Shock Factor: Independent Control of Transient and Sustained Transcriptional Activity
    The EMBO Journal vol.12 no.13 pp.5007-5018, 1993 Identification of the C-terminal activator domain in yeast heat shock factor: independent control of transient and sustained transcriptional activity Yuqing Chen1, Nickolai A.Barlev2,3, Introduction Ole Westergaard and Bent K.Jakobsen4 In response to hyperthermia, and certain other forms of Department of Molecular Biology, University of Aarhus, C.F.Mollers stress, cells transiently increase transcription from a small Alle, Building 130, DK-8000 Aarhus C, Denmark group of genes that encode a characteristic set of proteins, lPresent address: Department of Zoology, University of Western the heat shock proteins. The heat shock proteins exercise Ontario, London, Canada protective functions in the cell during stress, for instance 2Present address: Laboratory of Structural Genome Organization, Institute of Cytology, Tihkoretsky Avenue 4, 194064 St Petersburg, by renaturing or solubilizing denatured proteins (for reviews Russia see Lindquist, 1986; Pelham, 1986; Bienz and Pelham, 3Present address: Wistar Institute, Pennsylvania University, 1987). 3601 Spruce Street, Philadelphia, PA 19104-4268, USA Heat shock promoters contain a universal sequence 4Present address: Institute of Molecular Medicine, University of element that is necessary and sufficient for their Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK transcriptional activation (the heat shock element, HSE). This Communicated by H.R.B.Pelham was originally identified as a 14 bp sequence by deletion analysis of the Drosophila hsp7O promoter (Bienz and In yeast, heat shock factor (HSF) is a trimer that binds Pelham, 1982; Pelham, 1982; Pelham and Bienz, 1982). DNA constitutively but only supports high levels of Careful examination of the HSE has demonstrated that it can transcription upon heat shock.
    [Show full text]
  • The Functions of HSP70 in Normal Cells
    Chapter 1 A General Description of HSPs, The Molecular Structure of HSP70 and The HSP70 Cycle Abstract Fifty years ago the accidental switch of a temperature knob on the incubator where Ferruccio Ritossa kept his fruit flies started a new era, the epoch of heat shock proteins (HSP). In 1986 H. Pelham was the first to suggest that HSPs bind to denatured protein aggregates, thereby restricting their aggregation and breaking them by using ATP as an energy source. Among all HSPs, the protein with a molecu- lar weight of 70 kDa was found to be the most common, drew the most attention and is consequently the HSP we know the most about. HSP70 contains three domains: the ATPase N-domain which hydrolyzes ATP; the substrate domain which binds pro- teins, and the C-domain that forms the “lid” for the substrate domain. Because of its three-domain structure, HSP70 forms a unified ATPase cycle coupled with connec- tion and disconnection of the client protein. The “team” of HSP70 cycle regulators includes HSP40, which delivers clients to HSP70 and stimulates ATP hydrolysis; Hip, which assists HSP70 in retaining the client, and Bag-1 and HspBP1, which accelerate the dissociation of ADP and the release of the client protein. Keywords HSP70 • Hip • Bag-1 • HspBP1 • The HSP70 cycle In this first chapter, I will begin by telling you the amazing story about how heat shock proteins (HSPs) were discovered, their general characteristics, molecular structure and their functional cycle. 1.1 About the Discovery of HSP, or How Drosophila Melanogaster was Accidentally “Heated” The name itself—“heat shock proteins”—results from the simple fact that HSPs were first discovered in cells exposed to elevated temperatures.
    [Show full text]
  • Lecture Slides
    (J. American Chemical Association, 78, 3458-3459) The Secondary Structure of Complementary RNA E. Peter Geiduschek, John W. Moohr, and Smauel B. Weiss, Proceedings of The National Academy of Sciences, 48, 1078-1086, 1962. R.H. DOI RH, and S. SPIEGELMAN Homology test between the nucleic acid of an RNA virus and the DNA in the host cell. Science 1962 Dec 14 1270-2. MONTAGNIER L, SANDERS FK. REPLICATIVE FORM OF ENCEPHALOMYOCARDITIS VIRUS RIBONUCLEIC ACID. Nature. 1963 Aug 17;199:664-7. (Science 143, 1034-1036, March 6, 1964) WARNER RC, SAMUELS HH, ABBOTT MT, KRAKOW JS. (1963) Ribonucleic acid polymerase of Azotobacter vinelandii, II. Formation of DNA- RNA hybrids with single-stranded DNA as primer. Proc Natl Acad Sci U S A. 49:533-8. Double Stranded RNA as a Specific Biological Effector December 8, 2006 Karolinska Institute, Stockholm, Sweden Viral interference (Interferon) effects in animals M. Hoskins (1935) A protective action of neurotropic against viscerotropic yellow fever virus in Macacus rhesus. American Journal of Tropical Medicine, 15, 675-680 G. Findlay and F. MacCallum (1937) An interference phenomenon in relation to yellow fever and other viruses. J. Path. Bact. 44, 405-424. A. Isaacs and J. Lindenmann (1957) Virus Interference. I. The Interferon Proc. Royal Soc. B 147, 268-273. Proceedings of the National Academy of Sciences, USA, Volume 58, Pages 782-789. 1967 Promoter Make transgenic worms geneX Antisense Transcripts Interference (Development 113:503 [1991]) geneX Promoter Make transgeneic worms geneX SENSE Transcripts Also Interference! (Development 113:503 [1991]) In Vitro Promoter Make RNA in vitro geneX Antisense RNA Inject worm gonad Interference! (Guo and Kemphues, 1995) In Vitro geneX Promoter Make RNA in vitro geneX SENSE RNA Inject worm gonad Also Interference! (Guo and Kemphues, 1995) Craig Mello's RNAi Workshop: 1997 C.
    [Show full text]
  • Curriculum Vitae ANTHONY PAUL
    Curriculum Vitae ANTHONY PAUL BRETSCHER Personal: Address: Department of Molecular Biology and Genetics Weill Institute for Cell and Molecular Biology Weill Hall Room 257 Cornell University Ithaca, NY 14853-7202 Telephone: 607-255-5713 Fax: 607-255-5961 e-mail: [email protected] Web site: http://www.mbg.cornell.edu/cals/mbg/faculty- staff/faculty/bretscher.cfm Date of Birth: September 8, 1950 Place of Birth: Harwell, Berkshire, England Citizenship: USA, United Kingdom and Switzerland Marital Status: Married Janice Sperbeck, 5.21.1983 Children: Heidi (b. Nov. 1, 1986), Erika (b. April 24, 1991) Home Address: 293 Ellis Hollow Creek Road, Ithaca, NY 14850 Education: 1971 BA University of Cambridge, UK. Experimental Physics 1974 MA University of Cambridge, UK 1974 PhD University of Leeds. Bacterial Genetics. Advisor: Dr. Simon Baumberg 1974-1977 EMBO Postdoctoral Fellow, Stanford University, CA Advisor: Dr. A. Dale Kaiser 1977-1980 Max Planck Society Fellow, Max Planck Institute for Biophysical Chemistry. Goettingen, Germany. Advisor: Dr. Klaus Weber. Academic Appointments: 1980-1981 Assistant Professor, Department of Cell Biology, Southwestern Medical School, Dallas, TX 1981-1999 Assistant (1981-1987), Associate (1987-1993), Professor (1993-1999) Section of Biochemistry, Molecular and Cell Biology, Cornell University 1999-present Professor of Cell Biology, Department of Molecular Biology and Genetics, Cornell University, NY 2007-present Member, Weill Institute for Cell and Molecular Biology Administrative Appointments: 2007-2011 Associate
    [Show full text]
  • What Makes a Great Lab?
    COMMENT 1826 and acquired international renown. It attracted students from all over Europe and earned Liebig a reputation as a ‘chemist breeder’. His lab was an early example of the research and teaching establishments that SOURCE: LMB ARCHIVE LMB SOURCE: made the German universities the envy of many. It began as a single room, with a fire in the middle surrounded by work benches. Liebig’s work on the compositions of chemical substances and their reactions was outstand- ing, and his focus on agricultural, industrial and biological issues gave his research a highly topical flavour. He trained his protégés carefully, espe- cially in qualitative analysis. Students flocked to him, with the result that European chem- istry during the middle of the nineteenth century bore a distinctly Liebigian flavour as his students moved to influential positions elsewhere. The identification of state-of-the- art problems and the training of students to solve them characterize his achievements. Liebig’s initiative was widely adapted in the natural and biomedical sciences throughout Max Perutz, James Watson, John Kendrew and Francis Crick talk to a BBC presenter (centre) about the German university system. their Nobel prizes in 1962. Training was also part of the brief of physiologist Ivan Pavlov (1849–1936), but he brought his own organizational genius to bear on the ‘physiology factory’ that he masterminded in St Petersburg, Russia, What makes famously studying dogs. He adapted aspects of manufacturing to the production of sci- entific knowledge. Pavlov’s staff were among the first to specialize in different tasks: surgi- a great lab? cal, chemical, dog handling.
    [Show full text]
  • Heat Shock Proteins in Thermotolerance and Other Cellular Processes1
    [CANCER RESEARCH 47, 5249-5255, October 15, 1987) Perspectivesin CancerResearch Heat Shock Proteins in Thermotolerance and Other Cellular Processes1 Stephen W. Carper,2 John J. Duffy, and Eugene W. Gerner Department of Radiation Oncology and Cancer Center, The University of Arizona Health Sciences Center, Tucson, Arizona S5724 Heat shock proteins are a unique set of highly conserved erentially synthesized (for recent reviews, see Refs. 7-13). The proteins induced by heat and other stresses. Their role in expression of hsps and the amino acid sequence of several hsps cellular responses to stress is currently unclear, due in part to are highly conserved throughout evolution, implying that they a variety of experimental findings that are apparently contra may have some universally important function(s). It is com dictory. The purpose of this review is to evaluate the evidence monly accepted that the function of the hsps is either to protect regarding the role of lisps-' in cellular responses to stress and to cells against subsequent heat stress or to enhance the ability of speculate on other possible physiological functions of these cells to recover from the toxic effects of heat or other stresses. unique proteins. This Perspectives article evaluates current evidence regarding Over the past 10 years, hyperthermia has gained increasing this possible role of hsps and considers alternate effects of hsps acceptance as a mode of cancer treatment, especially when used on cellular physiological responses. in combination with radiotherapy (1). In 1985, the United States Food and Drug Administration formally recognized hy perthermia therapy, generally meaning the elevation of tumor Operational Definitions of hsps and Thermotolerance temperatures to 40-45°C, as an effective form of treatment for certain types of cancer.
    [Show full text]
  • Professor Tumani Corrah Honoured
    MRC May 2014 News from the MRC community The Chancellor visits the LMB to announce future support for science The Chancellor of the Exchequer, the Rt Hon George Osborne, visited the MRC Laboratory of Molecular Biology (LMB) in Cambridge on Friday 25 April to announce details of the long-term plan for science capital investment. Mr Osborne was welcomed by MRC LMB Director Sir Hugh Pelham and shown some of the world-class facilities in the new laboratory, which was opened by Her Majesty The Queen last May. In his speech, the Chancellor announced the launch of a consultation on allocating the Government’s £7 billion science capital budget. Mr Osborne lauded the LMB’s achievements and “fantastic pedigree” including the discovery of the structure of DNA, nine Nobel prizes and various spin-out companies. In response, Declan Mulkeen, MRC Chief Science Officer, said: “Government’s commitment to long-term, stable funding for research capital developments is very good news for medical research, and UK science overall.” The Chancellor and Dr Melina Schuh On his visit, the Chancellor was introduced to the work of Dr Melina Schuh, a Group Leader in the MRC LMB Cell Biology Division. Dr Schuh’s laboratory studies show how fertilisable eggs (oocytes) develop in mammals, with the long-term goal of identifying and analysing mechanisms that lead to abnormal eggs, which are the leading genetic cause of miscarriage and congenital birth defects. For further information please visit: www.mrc.ac.uk/Newspublications/News/MRC009816 Professor Tumani Corrah honoured On 10 April 2014 Professor Tumani Corrah, MRC Director, Africa Research Development, was invested with the title ‘Emeritus Director’ by Sir John Savill, MRC Chief Executive, at a ceremony attended by members of the MRC’s Management Board.
    [Show full text]
  • People & Ideas
    Published January 10, 2011 People & Ideas Sean Munro: Revealing the Golgi’s true identity Munro studies how proteins localize within the secretory pathway. lthough cargo proteins move I learnt about the molecular biology revolu- through the different organelles of tion that was happening, and that all seemed A the secretory pathway, other pro- very exciting. I studied Biochemistry at teins remain in place to give each compart- Oxford as an undergraduate. Molecular bi- ment its own unique identity and function. ology hadn’t quite reached Oxford yet, but Sean Munro, from the MRC Laboratory of there was a small amount going on, and I Molecular Biology in Cambridge, England, became interested in gene transcription. has been interested in how proteins ! nd their place within the secretory pathway since his How did that interest lead you to join PhD studies with Hugh Pelham, when he Hugh Pelham’s lab for your PhD? discovered a heat-shock protein that was re- He was working on the transcription of tained in the ER lumen due to a speci! c heat-shock genes at that time. But he was Downloaded from “KDEL” sequence at its C terminus (1). trying to diversify a bit when I got there, so OF MRC CAMBRIDGE IMAGE COURTESY Sean Munro After a brief detour into receptor biology he said, “Why don’t you work on heat-shock as a postdoc with Tom Maniatis, Munro be- proteins and try to understand what they’re gan his own lab and as an independent group actually doing?” He wanted me to study that a protein is not randomly distributed— leader moved from studying the ER to the Hsp70, but a competing lab was reluctant to it’s clearly in a speci! c place.
    [Show full text]
  • Report 1978 Cold Spring Harbor Laboratory
    COLDLABORATORY SPRING HARBOR ANNUAL REPORT 1978 COLD SPRING HARBOR LABORATORY COLD SPRING HARBOR, NEW YORK Cover: Participants at 1978 Symposium (top to bottom) G. Selzer, F. Stahl, and J. Strathern; A. Kornberg, A. Falaschi, and R. Holliday; W. Arber and D. Nathans; W. Udry, A. Bukhari, and D. Baltimore Picture credits: Cover, 82, 90, 140, Ross Meurer; 14, Cindy Carpenter; 19, W. Udry; 11, 12,13, 17, 20, 67, 136, 142, 143, 153, Robert Yaffe COLD SPRING HARBOR LABORATORY COLD SPRING HARBOR, LONG ISLAND, NEW YORK OFFICERS OF THE CORPORATION Dr. Harry Eagle, Chairman Edward Pulling, Vice-Chairman Dr. Bayard Clarkson, Secretary Clarence E. Galston, Treasurer Robert L. Cummings, Assistant Treasurer William R. Udry, Administrative Director BOARD OF TRUSTEES Institutional Trustees Albert Einstein College of Medicine University of Wisconsin Dr. Harry Julian Davies Columbia University Wawepex Society Dr. Charles R. Cantor Bache Bleecker Duke University Dr. Walter Guild Individual Trustees Long Island Biological Association Emilio G. Collado Edward Pulling Robert L. Cummings Massachusetts Institute of Technology Roderick H. Cushman Dr. Herman Eisen Norris Darrell Memorial Sloan-Kettering Cancer Center Walter N. Frank, Jr. Dr. Bayard Clarkson Clarence E. Galston Mary Lindsay New York University Medical Center William S. Robertson Dr. Vittorio Defendi Mrs. Franz Schneider Princeton University Alexander C. Tomlinson Dr. Arnold J. Levine Dr. James D. Watson The Rockefeller University Dr. Rollin Hotchkiss Honorary trustees State University of New York Dr. H. Bentley Glass at Stony Brook Dr. Alexander Hollaender Dr. Joseph R. Kates Officers and trustees listed are as of December 31, 1978 DIRECTOR'S REPORT The collective decisions of knowledgeable men go sourone likes to advertise that we may have no meaningful more often than we want.
    [Show full text]
  • Molecular Cloning and Characterization of the Mrna for Cyclin from Sea Urchin Eggs
    The EMBO Journal vol.6 no.10 pp.2987-2995, 1987 Molecular cloning and characterization of the mRNA for cyclin from sea urchin eggs Jonathon Pines and Tim Hunt mitosis (Hultin, 1961; Wilt et al., 1967; Wagenaar, 1983; University of Cambridge, Department of Biochemistry, Tennis Court Road, Newport and Kirschner, 1984). The hypothesis has recently Cambridge CB2 IQW, UK received strong support from the demonstration that microinjec- Communicated by T.Hunt tion of clam cyclin A mRNA induces meiotic maturation in Xenopus oocytes (Swenson et al., 1986), though it remains to We have isolated a cDNA clone encoding sea urchin cyclin be shown that cyclin can promote entry into mitosis in cyclo- and determined its sequence. It contains a single open reading heximide-arrested fertilized eggs. frame of 409 amino acids which shows homology with clam This paper reports the amino acid sequence of sea urchin cyclin, cyclins. RNA transcribed in vitro from this sequence was based on the DNA sequence of cyclin cDNA clones isolated from efficiently translated in reticulocyte lysates, yielding full-length Arbacia punctulata. Comparison of the clam cyclin A and ur- cyclin. Injection of nanogram amounts of this synthetic chin cyclin sequences, both of which are just over 400 residues mRNA into Xenopus oocytes caused them to mature more long, shows strong homology limited to a sequence of about 36 rapidly than with progesterone treatment. The sea urchin amino acids in the middle of the proteins. Despite the considerable cyclin underwent two posttranslational modifications in the sequence divergence at both ends of the proteins, microinjec- Xenopus oocytes during maturation.
    [Show full text]
  • Front Matter
    MOLECULAR AND CELLULAR BIOLOGY VOLUME 3 * NUMBER 12 * DECEMBER 1983 Aaron J. Shatkin, Editor in Chief (1985) Roche Institute of Molecular Biology Nutley, N.J. Harvey F. Lodish, Editor (1986) Louis Siminovitch, Editor (1985) Massachusetts Institute of Technology Hospital for Sick Children Cambridge, Mass. Toronto, Canada David J. L. Luck, Editor (1987) Paul S. Sypherd, Editor (1985) Rockefeller University University of California New York, N.Y. Irvine, Calif. EDITORIAL BOARD Renato Baserga (1985) Ira Herskowitz (1984) Daniel B. Rifkin (1985) Alan Bernstein (1984) Larry Kedes (1985) Robert G. Roeder (1985) J. Michael Bishop (1984) Marilyn Kozak (1985) James E. Rothman (1984) Joan Brugge (1985) Elias Lazarides (1985) Phillip A. Sharp (1985) Breck Byers (1985) John B. Little (1985) Fred Sherman (1985) John A. Carbon (1984) William F. Loomis, Jr. (1985) Pamela Stanley (1985) Lawrence A. Chasin (1985) Paul T. Magee (1985) Joan A. Steitz (1985) Nam-Hai Chua (1985) Robert L. Metzenberg (1985) James L. Van Etten (1985) Terrance G. Cooper (1984) Robert K. Mortimer (1985) Jonathan R. Warner (1984) James E. Darneil, Jr. (1985) Harvey L. Ozer (1985) Robert A. Weinberg (1984) Gary Felsenfeld (1985) Mary Lou Pardue (1985) I. Bernard Weinstein (1985) Norton B. Gilula (1985) Mark Pearson (1985) Harold Weintraub (1985) James E. Haber (1984) Jeremy Pickett-Heaps (1985) Reed B. Wickner (1985) Benjamin Hall (1985) Robert E. Pollack (1985) Leslie Wilson (1985) Ari Helenius (1984) Keith R. Porter (1985) Edward Ziff (1985) Susan A. Henry (1985) John R. Pringle (1985) Helen R. Whiteley, Chairman, Publications Board Walter G. Peter Ill, Director, Publications Linda M. Illig, Managing Editor, Journals Eleanor S.
    [Show full text]